Combination therapy glucocorticoids and ginsenoside

Abstract

Combination therapy glucocorticoids and ginsenoside The invention relates to a ginsenoside formulation comprising a PPT-type ginsenoside at least partly incorporated in a micelle, preferably at least partly incorporated in an outer layer of the micelle, said micelle having a molecular weight of at least 10.000 Da and a ginsenoside for use in a method of prevention or treatment of a side-effect of glucocorticoid (GC) treatment, said method comprising administering a ginsenoside to a subject that is suffering from, or at risk of suffering from, one or more side-effect(s) of GC treatment. The invention also relates to a combination of a glucocorticoid (GC) and a ginsenoside for use in a method of prevention or treatment of an inflammatory disease, wherein said method comprises administering a GC and a PPT-type ginsenoside in a particular molar ratio.

Dependencies are inferred from the claim text.